Frequently Asked Questions
Who makes the KineSpring® System?
Moximed, Inc (California, USA) makes the KineSpring System and is sponsoring the SOAR clinical trial. Visit www.moximed.com to learn more about the company.
Has the KineSpring System ever been used in patients before?
The KineSpring System has been implanted in patients in Australia since 2008 and in Europe since 2010.
Can I receive the KineSpring System without joining the SOAR Clinical Trial?
No, the KineSpring System is an investigational device in the U.S. and is currently only available to participants through the SOAR Clinical Trial.
Will I be paid to participate in the SOAR clinical trial?
You will not be paid to participate in this study.
What if I join the study then decide I don’t want to participate anymore?
Clinical study participation is voluntary, and you may leave the study at any time. Your decision to leave the study will not affect your medical care or relationship with your doctors.
Are there any costs involved in the SOAR Clinical Trial?
If you qualify and choose to join the SOAR Clinical Trial, you will receive all study-related care at no cost. This includes the KineSpring System, as well as any examinations and follow-up visits required for the study.
I am interested in hearing more. What is the next step?
To get connected with the local SOAR study center in your area, the next step is taking the pre-screening questionnaire. The questionnaire will help determine if you meet some of the main criteria for the study. If you pass the pre-screening questionnaire, you will be given the option to have your contact information sent directly to the local SOAR study center in your area. Someone from your local study center will then contact you within a couple of days to tell you more about the study, and help you decide whether you would like to participate. Please click here to see how you can take the pre-screening questionnaire.
To learn more about this therapy and find out if you qualify for this clinical trial, please click here.